Copeland Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $924K | Sell |
4,742
-87
| -2% | -$18K | 0.02% | 133 |
|
|
2026
Q1 | $1.08M | Buy |
4,829
+556
| +13% | +$139K | 0.02% | 129 |
|
|
2025
Q4 | $1.03M | Sell |
4,273
-197
| -4% | -$50.4K | 0.02% | 129 |
|
|
2025
Q3 | $1.22M | Sell |
4,470
-850
| -16% | -$232K | 0.03% | 128 |
|
|
2025
Q2 | $1.37M | Sell |
5,320
-185
| -3% | -$44.1K | 0.03% | 121 |
|
|
2025
Q1 | $1.23M | Sell |
5,505
-1,062
| -16% | -$248K | 0.02% | 119 |
|
|
2024
Q4 | $1.5M | Sell |
6,567
-257
| -4% | -$61.9K | 0.03% | 119 |
|
|
2024
Q3 | $1.67M | Sell |
6,824
-194
| -3% | -$43.4K | 0.03% | 122 |
|
|
2024
Q2 | $1.34M | Sell |
7,018
-244
| -3% | -$49.5K | 0.03% | 122 |
|
|
2024
Q1 | $1.44M | Sell |
7,262
-173
| -2% | -$31.7K | 0.03% | 120 |
|
|
2023
Q4 | $1.28M | Buy |
7,435
+3,547
| +91% | +$545K | 0.03% | 115 |
|
|
2023
Q3 | $575K | Sell |
3,888
-1,919
| -33% | -$347K | 0.01% | 128 |
|
|
2023
Q2 | $1.27M | Sell |
5,807
-286
| -5% | -$63.7K | 0.03% | 119 |
|
|
2023
Q1 | $1.33M | Sell |
6,093
-163
| -3% | -$35.4K | 0.03% | 116 |
|
|
2022
Q4 | $1.3M | Sell |
6,256
-213
| -3% | -$46.8K | 0.03% | 120 |
|
|
2022
Q3 | $1.41M | Sell |
6,469
-283
| -4% | -$64.4K | 0.05% | 117 |
|
|
2022
Q2 | $1.42M | Buy |
6,752
+1,279
| +23% | +$272K | 0.04% | 119 |
|
|
2022
Q1 | $1.33M | Buy |
5,473
+253
| +5% | +$61.2K | 0.04% | 121 |
|
|
2021
Q4 | $1.36M | Sell |
5,220
-179
| -3% | -$46.4K | 0.04% | 125 |
|
|
2021
Q3 | $1.42M | Sell |
5,399
-1,069
| -17% | -$292K | 0.04% | 122 |
|
|
2021
Q2 | $1.59M | Buy |
6,468
+95
| +1% | +$20K | 0.05% | 121 |
|
|
2021
Q1 | $1.24M | Sell |
6,373
-1,681
| -21% | -$337K | 0.04% | 125 |
|
|
2020
Q4 | $1.71M | Sell |
8,054
-85,320
| -91% | -$17M | 0.07% | 113 |
|
|
2020
Q3 | $16M | Sell |
93,374
-1,857
| -2% | -$343K | 0.71% | 59 |
|
|
2020
Q2 | $18.3M | Buy |
95,231
+1,511
| +2% | +$247K | 0.94% | 44 |
|
|
2020
Q1 | $13.8M | Buy |
93,720
+5,148
| +6% | +$820K | 0.84% | 52 |
|
|
2019
Q4 | $13.7M | Buy |
88,572
+17,495
| +25% | +$2.52M | 0.6% | 60 |
|
|
2019
Q3 | $9.6M | Sell |
71,077
-17,951
| -20% | -$2.35M | 0.49% | 66 |
|
|
2019
Q2 | $10.9M | Buy |
89,028
+15,707
| +21% | +$1.74M | 0.6% | 58 |
|
|
2019
Q1 | $7.62M | Buy |
73,321
+10,234
| +16% | +$1.06M | 0.48% | 65 |
|
|
2018
Q4 | $7.18M | Sell |
63,087
-47,457
| -43% | -$5.08M | 0.51% | 70 |
|
|
2018
Q3 | $12.8M | Buy |
110,544
+1,084
| +1% | +$119K | 0.77% | 65 |
|
|
2018
Q2 | $11.3M | Sell |
109,460
-441
| -0.4% | -$44.6K | 0.66% | 70 |
|
|
2018
Q1 | $10.8M | Sell |
109,901
-31,907
| -23% | -$3.02M | 0.69% | 70 |
|
|
2017
Q4 | $12M | Buy |
141,808
+2,577
| +2% | +$213K | 0.76% | 62 |
|
|
2017
Q3 | $10.7M | Sell |
139,231
-2,567
| -2% | -$196K | 0.73% | 61 |
|
|
2017
Q2 | $11M | Buy |
141,798
+24,056
| +20% | +$1.72M | 0.72% | 63 |
|
|
2017
Q1 | $8.52M | Sell |
117,742
-10,274
| -8% | -$710K | 0.59% | 76 |
|
|
2016
Q4 | $7.94M | Buy |
128,016
+364
| +0.3% | +$22.3K | 0.52% | 76 |
|
|
2016
Q3 | $8.27M | Sell |
127,652
-3,828
| -3% | -$255K | 0.53% | 80 |
|
|
2016
Q2 | $8.31M | Sell |
131,480
-8,735
| -6% | -$515K | 0.57% | 67 |
|
|
2016
Q1 | $8.11M | Sell |
140,215
-2,586
| -2% | -$146K | 0.56% | 76 |
|
|
2015
Q4 | $7.67M | Sell |
142,801
-1,394
| -1% | -$78.6K | 0.43% | 86 |
|
|
2015
Q3 | $7.35M | Buy |
144,195
+1,282
| +0.9% | +$69K | 0.45% | 83 |
|
|
2015
Q2 | $8.06M | Buy |
142,913
+123,592
| +640% | +$7.8M | 0.41% | 96 |
|
|
2015
Q1 | $1.39M | Sell |
19,321
-9,386
| -33% | -$610K | 0.09% | 114 |
|
|
2014
Q4 | $1.61M | Buy |
28,707
+25,054
| +686% | +$1.31M | 0.12% | 113 |
|
|
2014
Q3 | $180K | Hold |
3,653
| – | – | 0.02% | 160 |
|
|
2014
Q2 | $185K | Buy |
+3,653
| New | +$181K | 0.02% | 154 |
|
Other funds holding RMD
Copeland Capital Management's RMD Position: Q2 2026 in Review
Copeland Capital Management reduced its ResMed (RMD) stake by 1.8% in Q2 2026, selling an estimated $18K and leaving 4,742 shares worth $924K. The position accounts for 0.02% of the portfolio, ranked #133.
Copeland Capital Management first reported a position in RMD in Q2 2014 and has held it in 49 quarters since. The position peaked at $18.3M in Q2 2020. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Copeland Capital Management held 4,742 shares of ResMed worth $924K as of Q2 2026.
- Copeland Capital Management sold 87 ResMed shares in Q2 2026, an estimated $18K.
- ResMed made up 0.02% of Copeland Capital Management's portfolio in Q2 2026, its #133 holding.
- Copeland Capital Management first reported a position in ResMed in Q2 2014 and has held it in 49 quarters since.
- Copeland Capital Management's ResMed position peaked at $18.3M in Q2 2020.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Copeland Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.